IP Library › Granted Patent US 12,440,679
Granted Patent B2
US 12,440,679 · App. 17/651,705 · Granted Oct 14, 2025

Electric stimulation system

Inventors: Hank Bink (Golden Valley, MN); Erik J. Peterson (Fridley, MN); Louis Vera-Portocarrero (St. Anthony, MN); Vinod Sharma (Maple Grove, MN); Jiashu Li (Mounds View, MN)
Assignee: Medtronic, Inc.
A61N1/36139A61N1/36171
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,440,679
App. No.
17/651,705
Granted
Oct 14, 2025
Kind
B2
Abstract

An example method of cycling electric stimulation includes delivering, via an implantable device, electric stimulation to a patient in accordance with a first therapy program; monitoring, via the implantable device and while the electric stimulation is being delivered in accordance with the first therapy program, a biomarker; and responsive to determining the biomarker satisfies a threshold, delivering, via the implantable device, electric stimulation to the patient in accordance with a second therapy program that is different than the first therapy program.

Claims (39)

1. A method of cycling electric stimulation, the method comprising:

delivering, via an implantable device, electric stimulation to a patient in accordance with a first therapy program;

monitoring, via the implantable device and while the electric stimulation is being delivered in accordance with the first therapy program, a biomarker;

responsive to determining the biomarker satisfies a threshold, delivering, via the implantable device, electric stimulation to the patient in accordance with a second therapy program that is different than the first therapy program; and

responsive to determining the biomarker does not satisfy the threshold after delivering the electrical stimulation in accordance with the second therapy program, delivering, via the implantable device, electric stimulation to the patient in accordance with the first therapy program.

2. The method of claim 1 , wherein the biomarker comprises a first biomarker, the method further comprising:

monitoring, via the implantable device and while the electric stimulation is being delivered in accordance with the second therapy program, a second biomarker.

3. The method of claim 2 , wherein the first biomarker and the second biomarker are different biomarkers.

4. The method of claim 2 , wherein the first biomarker and the second biomarker are the same biomarker.

5. The method of claim 4 , wherein the threshold comprises a first threshold, the method further comprising:

responsive to determining the second biomarker satisfies a second threshold, delivering, via the implantable device, electric stimulation to the patient in accordance with the first therapy program.

6. The method of claim 1 , wherein delivering electric stimulation via the second therapy program comprises not delivering electric stimulation to the patient.

7. The method of claim 1 , wherein the first therapy program comprises electric stimulation comprising at least one frequency of at least 10 kHz.

8. The method of claim 1 , wherein the biomarker comprises at least one of a direct measure of symptoms, an accelerometer, a pressure sensor, a physiological signal, a cardiac signal, a respiratory signal, a body temperature, a patient posture, or an evoked compound action potential (ECAP).

9. The method of claim 1 , wherein the first therapy program comprises a first amount of electric stimulation, wherein the second therapy program comprises a second amount of electric stimulation, wherein the second amount of electric stimulation is less than the first amount of electric stimulation.

10. The method of claim 9 , wherein the second amount of electric stimulation is sufficient for capturing an evoked compound action potential (ECAP).

11. The method of claim 9 , wherein the first amount of electric stimulation comprises a first plurality of stimulation doses having a first on-time and a first off-time, wherein the second amount of electric stimulation comprises a second plurality of stimulation doses having a second on-time less than the first on-time and a second off-time greater than the first off-time.

12. The method of claim 9 , wherein the first amount of electric stimulation comprises a first plurality of stimulation doses having a first on-time and a first off-time, wherein the second amount of electric stimulation comprises a second plurality of stimulation doses having the first on-time and a plurality of second off-times that increase between subsequent stimulation doses of the second plurality of stimulation doses.

13. A system comprising:

an implantable device comprising electrodes configured to deliver electrical stimulation to a patient; and

a device comprising processing circuitry configured to:

cause the implantable device to deliver electric stimulation to a patient in accordance with a first therapy program;

monitor, via the implantable device and while the electric stimulation is being delivered in accordance with the first therapy program, a biomarker; and

responsive to determining the biomarker satisfies a threshold, cause the implantable device to deliver electric stimulation to the patient in accordance with a second therapy program; and

responsive to determining the biomarker does not satisfy the threshold after delivering the electrical stimulation in accordance with the second therapy program, cause the implantable device to deliver electric stimulation to the patient in accordance with the first therapy program.

14. The system of claim 13 , wherein the biomarker comprises a first biomarker, the processing circuitry further configured to:

monitor, via the implantable device and while the electric stimulation is being delivered in accordance with the second therapy program, a second biomarker.

15. The system of claim 14 , wherein the first biomarker and the second biomarker are the same biomarker.

16. The system of claim 15 , wherein the threshold comprises a first threshold, the processing circuitry further configured to:

responsive to determining the second biomarker satisfies a second threshold, cause the implantable device to deliver electric stimulation to the patient in accordance with the first therapy program.

17. The system of claim 13 , wherein the second therapy program comprises not delivering electric stimulation to the patient.

18. The system of claim 13 , wherein the biomarker comprises at least one of a direct measure of symptoms, an accelerometer, a pressure sensor, a physiological signal, a cardiac signal, a respiratory signal, a body temperature, a patient posture, or an evoked compound action potential (ECAP).

19. The system of claim 13 , wherein the first therapy program comprises a first amount of electric stimulation, wherein the second therapy program comprises a second amount of electric stimulation, where the second amount of electric stimulation is less than the first amount of electric stimulation.

20. The system of claim 19 , wherein the second amount of electric stimulation is sufficient for capturing an evoked compound action potential (ECAP).

21. A computer readable medium comprising instructions that when executed cause one or more processors to:

cause an implantable device to deliver electric stimulation to a patient in accordance with a first therapy program;

monitoring, via the implantable device and while the electric stimulation is being delivered in accordance with the first therapy program, a biomarker; and

responsive to determining the biomarker satisfies a threshold, cause the implantable device to deliver electric stimulation to the patient in accordance with a second therapy program; and

responsive to determining the biomarker does not satisfy the threshold after delivering the electrical stimulation in accordance with the second therapy program, cause the implantable device to deliver electric stimulation to the patient in accordance with the first therapy program.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2022
From: BINK, HANK; PETERSON, ERIK J.; VERA-PORTOCARRERO, LOUIS; SHARMA, VINOD; LI, JIASHU
To: MEDTRONIC, INC.
Reel/Frame 059643/0634 →
Continuity (2)
Provisional Application 63152867 · Feb 24, 2021
Related Publication 20220266028A1 · Aug 25, 2022
References Cited (12)
US 8032229B2 · Gerber et al. · 2011 [cited by applicant]
US 10183168B2 · Baru et al. · 2019 [cited by applicant]
US 20140350636A1 · King et al. · 2014 [cited by applicant]
US 20190022397A1 · Srivastava et al. · 2019 [cited by applicant]
US 20190209844A1 · Esteller et al. · 2019 [cited by applicant]
US 20190388692A1 · Dinsmoor et al. · 2019 [cited by applicant]
US 20200038660A1 · Torgerson · 2020 [cited by applicant]
US 20200171313A1 · Dinsmoor et al. · 2020 [cited by applicant]
US 20200179688A1 · Su · 2020 [cited by applicant]
US 20200261722A1 · Alataris · 2020 [cited by examiner]
US 20200384270A1 · Doan · 2020 [cited by examiner]
US 20210008371A1 · Annecchino · 2021 [cited by examiner]